In: Cardiovascular Medicine, 2012, vol. 15, no. 2, p. 48-52
|
In: Cardiovascular Medicine, 2012, vol. 15, no. 7-8, p. 228-229
|
In: Cardiovascular Medicine, 2012, vol. 15, no. 2, p. 62-63
|
In: Cardiovascular Medicine, 2012, vol. 15, no. 7-8, p. 226-227
|
In: Swiss Medical Weekly, 2012, vol. 142, p. w13608
Contrast-induced nephropathy (CIN) is an acute renal injury due to the renal toxicity of iodinated contrast media. It is classically defined as a relative (≥25%) or absolute (≥0.5 mg/dl; 44 μmol/l) increase in serum creatinine from baseline value. CIN accounts for 10 to 15% of hospital-acquired acute renal failure and may rarely lead to irreversible renal function loss. Following...
|
In: Cardiovascular Medicine, 2012, vol. 15, no. 12, p. 354–361
Objectives: We sought to determine the efficacy and safety of a scoring balloon for the treatment of in-stent restenosis (ISR). Background: The optimal therapy for ISR is not yet properly established and subject to many discussions. The GRIP™ Balloon (Acrostak, Switzerland) might be of interest for the treatment of certain types of ISR. Methods: Between 2003 and 2009, 157 patients who were...
|
In: Swiss Medical Weekly, 2012, vol. 142, p. w13661
|
In: PLoS ONE, 2012, vol. 7, no. 8, p. e43642
Aims: Cardiac grafts from non-heartbeating donors (NHBDs) could significantly increase organ availability and reduce waiting-list mortality. Reluctance to exploit hearts from NHBDs arises from obligatory delays in procurement leading to periods of warm ischemia and possible subsequent contractile dysfunction. Means for early prediction of graft suitability prior to transplantation are thus...
|
In: American Heart Journal, 2012, vol. 163, no. 2, p. 208–213
Background: Several parameters of cardiovascular physiology and pathophysiology exhibit circadian rhythms. Recently, a relation between infarct size and the time of day at which it occurs has been suggested in experimental models of myocardial infarction. The aim of this study is to investigate whether circadian rhythms could cause differences in ischemic burden in patients with ST-elevation...
|
In: Minimally Invasive Surgery, 2011, p. -
The development of ventricular assist devices has broadened the means with which one can treat acute heart failure. Percutaneous ventricular assist devices (pVAD) have risen from recent technological advances. They are smaller, easier, and faster to implant, all important qualities in the setting of acute heart failure. The present paper briefly describes the functioning and assets of the most...
|
